Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
915.50 DKK | +1.61% | +10.57% | +145.31% |
09-09 | Zealand Pharma's Weight Management Drug Shows Positive Topline Results in Early-stage Trial | MT |
09-09 | Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight | MT |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
1,022.29 | +11.66% | 7 | |||||||
1,162.19 | +0.77% | 25 | |||||||
509.82 | +5.04% | 29 | |||||||
510.75 | +4.66% | 15 | |||||||
99.35 | -10.73% | 18 | |||||||
272.96 | +37.52% | 21 | |||||||
18.79 | -23.10% | 3 | |||||||
2,409.94 | +33.89% | 17 | |||||||
58.78 | +47.62% | 18 | |||||||
145.00 | +25.00% | 7 | |||||||
87.50 | +17.20% | 16 | |||||||
168.72 | +38.01% | 25 | |||||||
194.36 | +55.93% | 19 | |||||||
82.93 | +64.84% | 19 | |||||||
59.10 | -5.14% | 10 | |||||||
27.52 | +4.02% | 21 | |||||||
856.00 | +25.51% | 4 | |||||||
109.70 | +64.39% | 13 | |||||||
164.73 | +53.42% | 13 | |||||||
Average | 418.97 | +23.71% | 16 | ||||||
Weighted average by Cap. | 611.12 | +11.28% | 21 |
- Stock Market
- Equities
- ZEAL Stock
- Sector Zealand Pharma A/S
- Sector consensus
MarketScreener is also available in this country: United States.
Switch edition